Y0002090

Regorafenib monohydrate

European Pharmacopoeia (EP) Reference Standard

• Sinónimos: 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide monohydrate
• Fórmula empírica (notación de Hill): C₂₁H₁₅ClF₄N₄O₃ · H₂O
• Número de CAS: 1019206-88-2
• Peso molecular: 500.83
• Código UNSPSC: 41116107
• NACRES: NA.24

Propiedades

• familia API: regorafenib
• fabricante / nombre comercial: EDQM
• temp. de almacenamiento: 2-8°C
• cadena SMILES: FC(F)(F)c1c(ccc(c1)NC(=O)Nc2c(cc(cc2)Oc3cc(ncc3)C(=O)NC)F)Cl.O
• InChI: 1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2
• Clave InChI: ZOPOQLDXFHBOIH-UHFFFAOYSA-N

Descripción

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Información de seguridad

• Pictogramas: GHS08,GHS09
• Palabra de señalización: Warning
• Frases de peligro: H361fd,H373,H410
• Consejos de prudencia: P201 - P273 - P308 + P313
• Clasificaciones de peligro: Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2
• Órganos de actuación: Liver
• Código de clase de almacenamiento: 13 - Non Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3
• Punto de inflamabilidad (°F): Not applicable
• Punto de inflamabilidad (°C): Not applicable